Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Resources for You

Resources for You

                        For Industry
          For Veterinarians


                        CVM en español
          Animal Health Literacy Home
          Animal & Veterinary
          Resources for You
          FDA response to commentary on studies involving the use of human critically important antimicrobials agents in veterinary speciesResources for You FDA response to commentary on studies involving the use of human critically important antimicrobials agents in veterinary species
  
  	
    Share
    Post
    Linkedin

    Email
    PrintThe U.S. Food and Drug Administration’s Center for Veterinary Medicine is aware of concerns raised in response to a recent commentary published in the Journal of Veterinary Pharmacology and Therapeutics, entitled “The publication of studies involving the use of human critically important antimicrobial agents in veterinary species.” This article, a commentary regarding editorial policy of veterinary journals, included a co-author affiliated with FDA but authoring in her own capacity. As stated in a disclaimer on the article, the information in the article is not intended to, nor does it, represent the formal position of FDA.

FDA has long advocated for the judicious use of medically important antimicrobials. The principles of FDA’s judicious use policy include 1) limiting medically important antimicrobial drugs to uses in food-producing animals that are considered necessary for assuring animal health; and 2) limiting medically important antimicrobial drugs to uses in food-producing animals to those that include veterinary oversight or consultation.

FDA does not wish, nor is it our intent, to impede scientific exploration or interfere with the editorial policies of scientific journals. We recognize the need for scientists to perform and publish data from studies that further the understanding of how antimicrobial agents affect human and animal health. The agency also does not wish to interfere in the practice of veterinary medicine, provided that veterinarians follow all relevant aspects of the Federal Food, Drug, and Cosmetic Act and associated Acts, such as the Animal Medicinal Drug Use Clarification Act (AMDUCA), which outlines how veterinary practitioners may use FDA-approved drugs in an extralabel manner.

There has been no change in FDA policy on judicious use of medically important antimicrobials, or its view on the use of these products in the course of scientific exploration. Consistent with ongoing efforts, the agency is committed to an approach that emphasizes collaboration, stakeholder engagement, and broad public input when developing or implementing new or revised policies to reduce the impact of antimicrobial resistance.

                                                                                  Content current as of:
      08/04/2023Resources for You

          
                        For Industry
          For Veterinarians


                        CVM en español
          Animal Health Literacy
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop